Tu Ho-Chou, Schwitalla Sarah, Qian Zhirong, LaPier Grace S, Yermalovich Alena, Ku Yuan-Chieh, Chen Shann-Ching, Viswanathan Srinivas R, Zhu Hao, Nishihara Reiko, Inamura Kentaro, Kim Sun A, Morikawa Teppei, Mima Kosuke, Sukawa Yasutaka, Yang Juhong, Meredith Gavin, Fuchs Charles S, Ogino Shuji, Daley George Q
Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02115, USA; Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA; Harvard Stem Cell Institute, Boston, Massachusetts 02115, USA;
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA;
Genes Dev. 2015 May 15;29(10):1074-86. doi: 10.1101/gad.256693.114. Epub 2015 May 8.
Colorectal cancer (CRC) remains a major contributor to cancer-related mortality. LIN28A and LIN28B are highly related RNA-binding protein paralogs that regulate biogenesis of let-7 microRNAs and influence development, metabolism, tissue regeneration, and oncogenesis. Here we demonstrate that overexpression of either LIN28 paralog cooperates with the Wnt pathway to promote invasive intestinal adenocarcinoma in murine models. When LIN28 alone is induced genetically, half of the resulting tumors harbor Ctnnb1 (β-catenin) mutation. When overexpressed in Apc(Min/+) mice, LIN28 accelerates tumor formation and enhances proliferation and invasiveness. In conditional genetic models, enforced expression of a LIN28-resistant form of the let-7 microRNA reduces LIN28-induced tumor burden, while silencing of LIN28 expression reduces tumor volume and increases tumor differentiation, indicating that LIN28 contributes to tumor maintenance. We detected aberrant expression of LIN28A and/or LIN28B in 38% of a large series of human CRC samples (n = 595), where LIN28 expression levels were associated with invasive tumor growth. Our late-stage CRC murine models and analysis of primary human tumors demonstrate prominent roles for both LIN28 paralogs in promoting CRC growth and progression and implicate the LIN28/let-7 pathway as a therapeutic target.
结直肠癌(CRC)仍然是癌症相关死亡率的主要促成因素。LIN28A和LIN28B是高度相关的RNA结合蛋白旁系同源物,它们调节let-7微小RNA的生物合成,并影响发育、代谢、组织再生和肿瘤发生。在此,我们证明,在小鼠模型中,任一LIN28旁系同源物的过表达与Wnt通路协同作用,促进侵袭性肠腺癌。当单独通过基因诱导LIN28时,所产生的肿瘤中有一半携带Ctnnb1(β-连环蛋白)突变。当在Apc(Min/+)小鼠中过表达时,LIN28加速肿瘤形成,并增强增殖和侵袭性。在条件性遗传模型中,强制表达一种对LIN28有抗性的let-7微小RNA形式可减轻LIN28诱导的肿瘤负担,而沉默LIN28表达可减小肿瘤体积并增加肿瘤分化,这表明LIN28有助于肿瘤维持。我们在一大系列人类CRC样本(n = 595)中的38%检测到LIN28A和/或LIN28B的异常表达,其中LIN28表达水平与侵袭性肿瘤生长相关。我们的晚期CRC小鼠模型和原发性人类肿瘤分析表明,两种LIN28旁系同源物在促进CRC生长和进展中均发挥重要作用,并表明LIN28/let-7通路是一个治疗靶点。